Artelo Biosciences (ARTL) announced that it has received a letter from Nasdaq confirming that the company has regained compliance with Nasdaq Listing Rule 5550, the “Equity Rule,” and Listing Rule 5620, the “Annual Shareholders Meeting Rule.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARTL:
- 3 Penny Stocks to Watch Now, 3/31/26
- Artelo Biosciences Soars 230% on Obesity Push — Why Is ARTL Stock Now Crashing?
- ARTL Upcoming Earnings Report: What to Expect?
- Artelo Biosciences announces $11M private placement priced at-the-market
- Artelo announces expansion opportunity for ART27.13 in muscle preservation